STEVEN TEBBS: Open Payments
NPI 1689300691 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 15 payments from 8 companies in 2025. Trend: 2023 $876 · 2024 $2,099 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $81 |
| Janssen Pharmaceuticals, Inc | 3 | $75 |
| ABBVIE INC. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Almatica Pharma LLC | 1 | $30 |
| Alkermes, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: VRAYLAR, COBENFY, REXULTI, ABILIFY MAINTENA, SPRAVATO, LOREEV XR, INVEGA SUSTENNA, ARISTADA.
Industry payments across AZ — which companies pay providers there.
